This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Amphastar Pharmaceuticals Inc
HubSpot, Inc.
Entrada Therapeutics Inc
The Trade Desk
Vital Farms, Inc.
Amphastar Pharmaceuticals Inc AMPH | 0.00 | |
HubSpot, Inc. HUBS | 0.00 | |
Entrada Therapeutics Inc TRDA | 0.00 | |
The Trade Desk TTD | 0.00 | |
Vital Farms, Inc. VITL | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jason Helfstein downgraded Trade Desk Inc (NASDAQ:TTD) from Outperform to Perform. Trade Desk shares closed at $23.49 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Matt Bullock downgraded HubSpot Inc (NYSE:HUBS) from Buy to Underperform and lowers the price target from $300 to $180. HubSpot shares closed at $243.72 on Thursday. See how other analysts view this stock.
- Stifel analyst Matthew Smith downgraded Vital Farms, Inc. (NASDAQ:VITL) from Buy to Hold and cut the price target from $34 to $10. Vital Farms shares closed at $9.52 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju downgraded Entrada Therapeutics (NASDAQ:TRDA) from Buy to Neutral. Entrada Therapeutics shares closed at $6.85 on Thursday. See how other analysts view this stock.
- Needham analyst Serge Belanger downgraded Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) from Buy to Hold. Amphastar Pharma shares closed at $24.03 on Thursday. See how other analysts view this stock.
Considering buying HUBS stock? Here’s what analysts think:
Photo via Shutterstock